May 25, 2023
|
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
|
May 04, 2023
|
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
|
Apr 27, 2023
|
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
|
Apr 18, 2023
|
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
|
Mar 02, 2023
|
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
|
Feb 28, 2023
|
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
|
Feb 23, 2023
|
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
|
Jan 05, 2023
|
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
|